Objective. To examine the gap between the current social/medical practice a
nd the evidence-based recommendation in favor of breastfeeding during mater
nal propylthiouracil (PTU) therapy.
Design. Prospective, observational, cohort study.
Subjects. Women requiring PTU during pregnancy, and endocrinologists and fa
mily physicians in Ontario, Canada.
Interventions. Questionnaire.
Main Outcome Measures. Women were interviewed postpartum regarding their ch
oice of infant feeding method and relevant advice received from physicians.
Physicians were questioned about their advice to nursing women receiving P
TU.
Results. Of 78 women, 66 had live births. Thirty-six required PTU postpartu
m (group 1), and 30 did not (group 2). Thirty-six healthy women served as c
ontrols (group 3). Breastfeeding initiation rates for groups 1, 2, and 3 we
re 44%, 83%, and 83%, respectively. In group 1, 15 women who breastfed rece
ived advice from 22 physicians regarding breastfeeding (20 in favor, 1 agai
nst, and 1 equivocal). Eleven who formula fed received advice from 17 physi
cians (4 in favor, 12 against, and 1 equivocal). A logistic regression anal
ysis of group 1 showed that physicians' advice was the only significant pre
dictor of the woman's choice to breastfeed during PTU therapy (relative ris
k: 5.48; 95% confidence interval: 1.28-23.40). The physician survey showed
that 44% of endocrinologists do not recommend breastfeeding during PTU ther
apy.
Conclusions. A substantial proportion of the lactating patients on PTU stil
l receive advice against breastfeeding from their physicians. Physicians' a
dvice and attitudes toward breastfeeding during PTU therapy are a major fac
tor in women's final decision to breastfeed. Physicians' compliance with ev
idence-based data will facilitate breastfeeding in this group.